Composition
- Active ingredients
- EVEROLIMUS 2MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- EVEROLIMUS 0.75MG · TabletANDA205432-003 · Prescription
- EVEROLIMUS 0.25MG · TabletANDA205432-001 · Prescription
- EVEROLIMUS 1MG · TabletANDA205432-004 · Prescription
- EVEROLIMUS 0.5MG · TabletANDA205432-002 · Prescription
- EVEROLIMUS 1MG · TabletANDA214138-004 · Prescription
- EVEROLIMUS 0.5MG · TabletANDA214138-002 · Prescription
- EVEROLIMUS 0.75MG · TabletANDA214138-003 · Prescription
- EVEROLIMUS 0.25MG · TabletANDA214138-001 · Prescription
- EVEROLIMUS 10MG · TabletANDA214182-004 · Prescription
- EVEROLIMUS 5MG · TabletANDA214182-002 · Prescription
- EVEROLIMUS 7.5MG · TabletANDA214182-003 · Prescription
- EVEROLIMUS 2.5MG · TabletANDA214182-001 · Prescription
- EVEROLIMUS 3MG · Tablet, for suspensionANDA217640-002 · Prescription
- EVEROLIMUS 5MG · Tablet, for suspension
At a glance
- Brand name
- Everolimus
- Route
- Oral
- Dosage form
- Tablet, for suspension
- Applicant
- Mylan
- Status
- Discontinued
- FDA approval
- 19 Apr 2019
- Application
- ANDA210130-001